Neurophysiology of Fibromyalgia
Key facts
- Who runs it
- McMaster University
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 1 Feb 2024
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
- Sham Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
- Record updated
- 4 June 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- 18-65 years old
Who cannot take part
- contraindications to TMS
- chronic pain associated with diagnoses other than fibromyalgia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Fibromyalgia is a syndrome associated with fatigue and chronic pain, leading to significant physical limitations and impaired quality of life. There are several challenges that complicate the diagnosis and management of fibromyalgia. The etiology is not well defined, as there are several proposed factors that may trigger the genesis of pain in fibromyalgia including physical and/or emotional life stressors, and genetic predispositions involving neuromodulator pathways. Chronic pain in fibromyalgia arises in the absence of tissue pathology, and consequently a lack of consensus on reliable diagnostic criteria. Understanding the neurophysiology of fibromyalgia would aid in the discovery of objective biomarkers for diagnosis. Therefore, the goals of this study are to:
Read full original descriptionShow less
1. Compare the neurophysiological responses in fibromyalgia compared to healthy controls. 2. Determine whether a two-week cTMS protocol will alter pain in individuals with fibromyalgia.
The 2 groups in the trial
- Active cTMSExisting treatment, for comparison
Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS) will be delivered at 10 Hz, 2000 pulses targeting the hand representation of the left primary motor cortex. cTMS delivery will require \~11 min to complete. In Experiment 1, this intervention will be performed for 1 session (\~11min). In Experiment 2, this intervention will be performed approximately 5 days per week for 2 weeks. In addition, participants will experience their standard medical care.
Treatment: Active Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
- Sham cTMSSham treatment, for comparison
Sham cTMS will be delivered at as a placebo control. It is important to note that from the participant perspective, the sham stimulation will feel and sound identical to active cTMS. In Experiment 2, this intervention will be performed approximately 5 days per week for 2 weeks. In addition, participants will experience their standard medical care.
Treatment: Sham Controlled Pulse Parameter Transcranial Magnetic Stimulation (cTMS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Neurobiological Contributions to Pain in Patients With Fibromyalgia
- Record updated
- 4 June 2026